RVL Pharmaceuticals PLC
(OTCPK:RVLPQ)
$
0.000010
-0.0000090 (-90%)
Market Cap: 0
Enterprise Value: 0
PE Ratio: 0
PB Ratio: 0
GF Score: 12/100 Osmotica Pharmaceuticals PLC at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 09, 2021 / 02:45PM GMT
Release Date Price:
$3.68
(+3.95%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
Good morning, everyone. My name is Balaji Prasad, and I lead the specialty pharma coverage for Barclays. Thank you for dialing into the Barclays Global Healthcare Conference, still in a virtual format.
We have with us today the management team from Osmotica, Brian Markison and Andy Einhorn. So I -- the format will be a presentation from the team.
And Brian and Andy, I'll let you guys take over. Thank you.
Brian and Andy, I think you're on mute.
Brian A. Markison
Osmotica Pharmaceuticals plc - Chairman, President & CEO
Here we go. All right. How are you? Good?
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
I'm good. Yes.
Brian A. Markison
Osmotica Pharmaceuticals plc - Chairman, President & CEO
Very good. All right. Good morning, and good afternoon, everybody. This is Brian Markison. And with me today is Andrew Einhorn, our CFO; and JD Schaub, Chief
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot